Viewing Study NCT05805605


Ignite Creation Date: 2025-12-25 @ 3:33 AM
Ignite Modification Date: 2026-01-28 @ 8:24 PM
Study NCT ID: NCT05805605
Status: RECRUITING
Last Update Posted: 2025-07-01
First Post: 2023-02-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Allo HSCT Using RIC and PTCy for Hematological Diseases
Sponsor: Masonic Cancer Center, University of Minnesota
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myelogenous Leukemia View
None Acute Lymphocytic Leukemia View
None Biphenotypic Acute Leukemia View
None Undifferentiated Leukemia View
None Prolymphocytic Leukemia View
None Chronic Myelogenous Leukemia View
None Plasma Cell Leukemia View
None Myelodysplastic Syndromes View
None Leukemia, Myeloid View
None Myelodysplastic Syndrome With Excess Blasts-1 View
None Burkitt Lymphoma View
None Relapsed T-Cell Lymphoma View
None Relapsed Chronic Lymphocytic Leukemia View
None Small Lymphocytic Lymphoma View
None Marginal Zone Lymphoma View
None Follicular Lymphoma View
None Myeloproliferative Neoplasm View
None Myelofibrosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MDS View
None CLL View
None SLL View
None AML View
None CML View
None PFS View
None TRM View
None GVHD View
None MMF View
None TBI View
None PTCy View
None ALL View